tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ONCR

Oncorus Announces Workforce Reduction Plan
Press ReleasesOncorus Announces Workforce Reduction Plan
11M ago
ONCR
Oncorus Reports First Quarter 2023 Financial Results and Provides Business Updates
PremiumPress Releases
Oncorus Reports First Quarter 2023 Financial Results and Provides Business Updates
11M ago
ONCR
Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
PremiumPress Releases
Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
1y ago
ONCR
Oncorus expects cash to fund expenditures into early 2024
PremiumThe Fly
Oncorus expects cash to fund expenditures into early 2024
1y ago
ONCR
Oncorus reports Q4 EPS (81c), consensus (76c)
PremiumThe Fly
Oncorus reports Q4 EPS (81c), consensus (76c)
1y ago
ONCR
Oncorus informs investors of holdings with SVB Financial
PremiumThe FlyOncorus informs investors of holdings with SVB Financial
1y ago
ONCR
SIVB
Oncorus announces research collaboration with Daewoong Pharmaceutical
PremiumThe Fly
Oncorus announces research collaboration with Daewoong Pharmaceutical
1y ago
ONCR
Oncorus downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Oncorus downgraded to Neutral from Buy at H.C. Wainwright
1y ago
ONCR
Oncorus downgraded to Neutral from Buy at Chardan
PremiumThe Fly
Oncorus downgraded to Neutral from Buy at Chardan
1y ago
ONCR
Piper downgrades Oncorus with plug pulled on lead program
PremiumThe Fly
Piper downgrades Oncorus with plug pulled on lead program
1y ago
ONCR
Oncorus downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Oncorus downgraded to Neutral from Overweight at Piper Sandler
1y ago
ONCR
Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with Cancer
PremiumPress Releases
Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with Cancer
1y ago
ONCR
Oncorus announces reprioritization of lead product candidate ONCR-021
PremiumThe FlyOncorus announces reprioritization of lead product candidate ONCR-021
1y ago
ONCR
Oncorus to Participate in Upcoming Investor Conferences
PremiumPress Releases
Oncorus to Participate in Upcoming Investor Conferences
1y ago
ONCR
Oncorus Presents Preclinical Data Supporting ONCR-719, an armed HSV-1 Vector engineered to use the Epidermal Growth Factor Receptor (EGFR/EGFRvIII) for viral entry in Glioblastoma, at the 2022 Society for Neuro-Oncology Annual Meeting
PremiumPress Releases
Oncorus Presents Preclinical Data Supporting ONCR-719, an armed HSV-1 Vector engineered to use the Epidermal Growth Factor Receptor (EGFR/EGFRvIII) for viral entry in Glioblastoma, at the 2022 Society for Neuro-Oncology Annual Meeting
1y ago
ONCR
Oncorus Announces Publication in Nature Communications Highlighting the Development of its Intravenously Administered Synthetic vRNA/LNP Platform for the Treatment of Cancer
PremiumPress Releases
Oncorus Announces Publication in Nature Communications Highlighting the Development of its Intravenously Administered Synthetic vRNA/LNP Platform for the Treatment of Cancer
2y ago
ONCR
Oncorus to Present at Chardan’s 6th Annual Genetic Medicines Conference
PremiumPress Releases
Oncorus to Present at Chardan’s 6th Annual Genetic Medicines Conference
2y ago
ONCR
Oncorus to Present at the H.C. Wainwright 24th Annual Global Investment Conference
PremiumPress Releases
Oncorus to Present at the H.C. Wainwright 24th Annual Global Investment Conference
2y ago
ONCR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >